Comments Submitted to the FDA Regarding Reauthorization of the Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027 (MDUFA V)

View as PDF

In a comments submitted to the Food and Drug Administration (FDA), Public Citizen urged the agency to revise its draft commitment letter regarding the Medical Device User Fee Amendments for fiscal years 2023 to 2027 (MDUFA V) to strengthen its independence from regulated industry and its regulatory oversight of medical devices.

See Public Citizen’s other work regarding the medical device review process.